Quest Diagnostics (MEX:DGX) Accounts Payable: MXN0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DGX Quest Diagnostics Inc MEX:DGX
71 GF Score
Price MXN3,624.00
GF Value MXN3,302.49
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Quest Diagnostics Accounts Payable?

Quest Diagnostics MEX:DGX 71 Accounts Payable is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:DGX with a GF Score™ of 71/100 and a GF Value™ of MXN3,302.49 (Fairly Valued). The stock has 8 warning signs investors should review.

Quest Diagnostics's Accounts Payable for the quarter that ended in Mar. 2026 was MXN0 Mil.

Quest Diagnostics's quarterly Accounts Payable increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN5,528 Mil) but then declined from Dec. 2025 (MXN5,528 Mil) to Mar. 2026 (MXN0 Mil).

Quest Diagnostics's annual Accounts Payable declined from Dec. 2023 (MXN6,416 Mil) to Dec. 2024 (MXN5,986 Mil) and declined from Dec. 2024 (MXN5,986 Mil) to Dec. 2025 (MXN5,528 Mil).

Quest Diagnostics Accounts Payable Related Terms

Quest Diagnostics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Quest Diagnostics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics Accounts Payable Chart

Quest Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,323.50 6,316.70 6,416.27 5,985.59 5,527.75

Quest Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 5,527.75 0.00
MEX:DGX
71GF Score
Quest Diagnostics Inc MEX:DGX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Diagnostics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of MXN0 Mil mean?
Quest Diagnostics (MEX:DGX) has a Accounts Payable of MXN0 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Quest Diagnostics and its competitors.
Is Quest Diagnostics' Accounts Payable too high?
Quest Diagnostics' current Accounts Payable is MXN0 Mil. Overall, Quest Diagnostics has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Quest Diagnostics' Accounts Payable compare to LH and MTD?
Quest Diagnostics' Accounts Payable of MXN0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Quest Diagnostics and its competitors. Quest Diagnostics's current Accounts Payable is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Quest Diagnostics (MEX:DGX) is currently considered Fairly Valued. The stock's GF Value™ is MXN3,302.49, compared to a current price of MXN3,624.00 — trading 9.7% above its estimated fair value. The current Accounts Payable is MXN0 Mil. Quest Diagnostics' overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Quest Diagnostics (MEX:DGX), the current Accounts Payable is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quest Diagnostics (MEX:DGX) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of MXN3,624.00 is trading 9.7% above its estimated GF Value™ of MXN3,302.49. GuruFocus considers Quest Diagnostics to be Fairly Valued.

Key valuation signals for MEX:DGX:

  • Accounts Payable: MXN0 Mil
  • GF Value™: MXN3,302.49 vs. price of MXN3,624.00 (9.7% above fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the MEX:DGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
71GF Score

Get the complete analysis for MEX:DGX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,624.00
Price
MXN3,302.49
GF Value